Nanoprobe-based regulation mainly focuses on pre-removal of tumor suppressor T cell recruitment factors such as TGF-β to activate the T cells (Zheng et al., 2017) and on normalization of tumor vasculature with vascular endothelial growth factor (VEGF) antibodies (Stephan et al., 2015). This evidence concerns the gene VEGFA and neoplasm.